Related references
Note: Only part of the references are listed.The non-small-cell lung cancer drug market
Khurram Nawaz et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells
Ding-Guo Wu et al.
TOXICOLOGY LETTERS (2014)
Targeting apoptosis pathways in cancer by Chinese medicine
Min Li-Weber
CANCER LETTERS (2013)
Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions
Hongqin Zhuang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin
Leong-Perng Chan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells
Hye-Sook Seo et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Apigenin Induces Apoptosis in Human Leukemia Cells and Exhibits Anti-Leukemic Activity In Vivo
Amit Budhraja et al.
MOLECULAR CANCER THERAPEUTICS (2012)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns
Jing Cai et al.
PHYTOMEDICINE (2011)
Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis
Hongqin Zhuang et al.
LUNG CANCER (2010)
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Devalingam Mahalingam et al.
CANCER TREATMENT REVIEWS (2009)
Bcl-2 siRNA Augments Taxol Mediated Apoptotic Death in Human Glioblastoma U138MG and U251MG Cells
Joseph George et al.
NEUROCHEMICAL RESEARCH (2009)
Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer
Sang Hyub Lee et al.
CANCER LETTERS (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells
Irene Crespo et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Involvement of ROS/ASMase/JNK signalling pathway in inhibiting UVA-induced apoptosis of HaGaT cells by polypeptide from Chlamys farreri
Yan-Xia Xing et al.
FREE RADICAL RESEARCH (2008)
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Han C. Dan et al.
GENES & DEVELOPMENT (2008)
Decoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-κB-Dependent Pathway
Pei-Hsuan Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-α-dependent and estrogen receptor-α-independent mechanisms
Xinghua Long et al.
MOLECULAR CANCER THERAPEUTICS (2008)
JNK signaling in apoptosis
D. N. Dhanasekaran et al.
ONCOGENE (2008)
Cross-talk between the Akt and NF-κB Signaling Pathways Inhibits MEHP-Induced Germ Cell Apoptosis
Rachel Rogers et al.
TOXICOLOGICAL SCIENCES (2008)
Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells
Wei-Jiunn Lee et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation
Courtney Nicholas et al.
JOURNAL OF IMMUNOLOGY (2007)
Barriers to effective TRAIL-targeted therapy of malignancy
Martin J. S. Dyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases:: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
Barry R. Davies et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Blockade of β-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice
Sanjeev Shukla et al.
CANCER RESEARCH (2007)
Aberrant NF-kappa B signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Philipp J. Jost et al.
BLOOD (2007)
Current insights into the regulation of programmed cell death by NF-κB
J. Dutta et al.
ONCOGENE (2006)
Curcurnin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells
Surajit Karmakar et al.
NEUROSCIENCE LETTERS (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
α-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route:: Implication for sensitisation of resistant cancer cells to TRAIL apoptosis
M Tomasetti et al.
FEBS LETTERS (2006)
Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft
S Shukla et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Apigenin induces apoptosis in Hep G2 cells:: Possible role of TNF-α and IFN-γ
TH Khan et al.
TOXICOLOGY (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
p53 upregulates death receptor 4 expression through an intronic p53 binding site
XG Liu et al.
CANCER RESEARCH (2004)
Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining
B Daniel et al.
BRAIN RESEARCH PROTOCOLS (2004)
Linking JNK signaling to NF-κB:: a key to survival
S Papa et al.
JOURNAL OF CELL SCIENCE (2004)
Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis
S Fujioka et al.
ONCOGENE (2003)
Apo2L/TRAIL and its death and decoy receptors
HN LeBlanc et al.
CELL DEATH AND DIFFERENTIATION (2003)
Activation of the PI3K/Akt pathway and chemotherapeutic resistance
KA West et al.
DRUG RESISTANCE UPDATES (2002)
c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
DW Chang et al.
EMBO JOURNAL (2002)
Share Paper
